Practical approach to the use of intravenous immunoglobulin in neurological disease

被引:11
作者
Wills, AJ
Unsworth, DJ
机构
[1] UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England
[2] Southmead Hosp, Dept Clin Immunol, Bristol, Avon, England
关键词
intravenous immunoglobulin; neurological indications; guidelines;
D O I
10.1159/000007891
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Intravenous immunoglobulin is now used in a wide range of neurological conditions. However, side effects are relatively common, treatment is expensive and sustained benefit unusual without repeated administration. This article aims to provide clinicians with an overview of the potential benefits and drawbacks of intravenous immunoglobulin in neurological practice and concludes with suggested guidelines for its use in adults.
引用
收藏
页码:3 / 8
页数:6
相关论文
共 56 条
[1]  
ACHIRON A, 1995, ISRAEL J MED SCI, V31, P7
[2]   TREATMENT OF STIFF-MAN SYNDROME WITH INTRAVENOUS IMMUNOGLOBULIN [J].
AMATO, AA ;
CORNMAN, EW ;
KISSEL, JT .
NEUROLOGY, 1994, 44 (09) :1652-1654
[3]   INCLUSION-BODY MYOSITIS - TREATMENT WITH INTRAVENOUS IMMUNOGLOBULIN [J].
AMATO, AA ;
BAROHN, RJ ;
JACKSON, CE ;
PAPPERT, EJ ;
SAHENK, Z ;
KISSEL, JT .
NEUROLOGY, 1994, 44 (08) :1516-1518
[4]  
ANDERSSON JP, 1990, IMMUNOLOGY, V71, P372
[5]   UVEITIS AFTER ANTINEUTROPHIL CYTOPLASMIC ANTIBODY CONTAMINATION OF IMMUNOGLOBULIN REPLACEMENT THERAPY [J].
AYLIFFE, W ;
HAENEY, M ;
ROBERTS, SC ;
LAVIN, M .
LANCET, 1992, 339 (8792) :558-559
[6]   INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN PATIENTS WITH MOTOR-NEURON SYNDROMES ASSOCIATED WITH ANTI-GM1 ANTIBODIES - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
AZULAY, JP ;
BLIN, O ;
POUGET, J ;
BOUCRAUT, J ;
BILLETURC, F ;
CARLES, G ;
SERRATRICE, G .
NEUROLOGY, 1994, 44 (03) :429-432
[7]   Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome [J].
Bain, PG ;
Motomura, M ;
NewsomDavis, J ;
Misbah, SA ;
Chapel, HM ;
Lee, ML ;
Vincent, A ;
Lang, B .
NEUROLOGY, 1996, 47 (03) :678-683
[8]  
BASTA M, 1991, BLOOD, V78, P700
[9]   HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN EXERTS ITS BENEFICIAL EFFECT IN PATIENTS WITH DERMATOMYOSITIS BY BLOCKING ENDOMYSIAL DEPOSITION OF ACTIVATED COMPLEMENT FRAGMENTS [J].
BASTA, M ;
DALAKAS, MC .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) :1729-1735
[10]   OPINIONS ABOUT PLASMA-EXCHANGE AND ASSOCIATED TREATMENTS IN THE THERAPY OF MYASTHENIA-GRAVIS [J].
BERGAMINI, L ;
COCITO, D ;
DURELLI, L ;
QUATTROCOLO, G .
MUSCLE & NERVE, 1983, 6 (06) :457-458